News
In a recent study, CBD was shown to suppress localized T-cell function and activity. This suggests that the cannabinoid may be the only scientifically-backed drug prove to to be capable of treating the underlying cause of RA.
The efficacy and safety of CBD to reduce pain and inflammation in the treatment of patients with persistent symptoms of RA and AS is beginning to gain traction in the medical community as controlled studies are consistently producing promising results.
Emerging research suggests that cannabinoids like CBD and CBG may support cardiovascular health by lowering blood pressure, reducing inflammation, and protecting against oxidative stress. Studies indicate that these compounds promote vasorelaxation, improve arterial function, and may even help prevent heart-related damage like ischemia/reperfusion injury. While not a replacement for traditional treatments, CBD and CBG offer a promising natural approach to heart health by interacting with the endocannabinoid system to regulate stress responses and circulation. As research evolves, cannabinoid-based therapies could become a game-changer in cardiovascular medicine.
Lichen sclerosus (LS) is a chronic inflammatory skin condition causing itching, pain, and skin thinning. While corticosteroids are the standard treatment, cannabinoids like CBD and CBG show promise in reducing inflammation, calming nerve-related itching, and supporting skin repair. Though clinical studies on LS are lacking, research suggests CBD’s anti-inflammatory and soothing effects may help. CBD-infused lubricants may also improve moisture, reduce pain, and enhance comfort during intimacy. With a strong safety profile, combining a CBD tincture for systemic relief and a topical for targeted support is a low-risk, high-reward option—because hydrated, less irritated skin is always a win.
